Levodopa induces apoptosis in cultured neuronal cells - A possible accelerator of nigrostriatal degeneration in Parkinson's disease?

Movement Disorders

Volumn 12, Issue 1, 1997, Pages 17-23

  Ziv, Ilan ^a   Zilkha Falb, Rina ^b   Offen, Daniel ^a   Shirvan, Anat ^a   Barzilai, Ari ^b   Melamed, Eldad ^a  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Apoptosis; Levodopa; Oxidative stress; Parkinson's disease; Toxicity

Indexed keywords

ACETYLCYSTEINE; DITHIOTHREITOL; LEVODOPA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CHICKEN; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG INHIBITION; NERVE CELL; NERVE CELL CULTURE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SYMPATHETIC NERVE CELL; TOXICITY;

ANIMALS; ANTIOXIDANTS; ANTIPARKINSON AGENTS; APOPTOSIS; CELL COUNT; CELL SURVIVAL; CELLS, CULTURED; CHICK EMBRYO; CORPUS STRIATUM; CYCLOHEXIMIDE; DACTINOMYCIN; FLOW CYTOMETRY; GANGLIA, SYMPATHETIC; HUMANS; LEVODOPA; MICROSCOPY, FLUORESCENCE; NERVE DEGENERATION; NEURONS; PARKINSON DISEASE; SUBSTANTIA NIGRA;

EID: 0031023430     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.870120105     Document Type: Article

References (12)

1. Graham DG. Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol Pharmacol 1978;14:633-643.
2. Graham DJ, Tiffany SM, Bell WR, Gutknecht WF. Autooxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward c1300 neuroblastoma cells in vitro. Mol Pharmacol 1978;14:644-653.
3. Rosenberg PA. Catecholamine toxicity in cerebral cortex in dissociated cell culture. J Neurol Sci 1988;8:2887-2894.
4. Olney JW, Zorumski CF, Stewart GR, Price MT, Wang G, Labruyere J. Excitotoxicity of L-DOPA and 6-OH-DOPA: implications for Parkinson's and Huntington's diseases. Exp Neural 1990;108:269-272.
5. Mytilineou C, Han SK, Cohen G. Toxic and protective effects of L-DOPA on mesencephalic cell cultures. J Neurochem 1993;61:1470-1478.
6. Mena MA, Pardo B, Casarejos MJ, Fahn S, De-Yebenes JG. Neurotoxicity of levodopa on catecholamine-rich neurons. Mov Disord 1992;7:23-31.
7. Wick MM, Byers L, Frei E. L-Dopa: selective toxicity for melanoma cells in vitro. Science 1977;197:468-469.
8. Wick MM. Levodopa and dopamine analogs: melanin precursors as antitumor agents in experimental human and murine leukemia. Cancer Treat Rep 1979;63:991-997.
9. Yahr MD. Long term levodopa therapy for Parkinson's disease. Lancet 1977:1:706-707.
10. Hefti F, Melamed E, Bhawan J, Wurtman RJ. Long-term administration of L-dopa does not damage dopaminergic neurons in the mouse. Neurology 1981;31:1194-1195.
11. Perry TL, Yong VW, Ito M, et al. Nigrostriatal dopaminergic neurons remain undamaged in rats given high doses of L-DOPA and carbidopa chronically. J Neurochem 1984;43:990-993.
12. Cotzias G, Miller ST, Tang LC, Papavasiliou PS. Levodopa, fertility and longevity. Science 1977;196:549-551.